Fig. 10

Tumor mutation and drug sensitivity analyses of patients at different risk statuses. A Genetic mutation landscape in the entire TCGA-LIHC cohort, with the top 30 genes displayed in the waterfall plot. B Waterfall plots showed the genetic mutation features both in the high- (left) and low-risk (right) groups. C Violin plot of the comparison of the TIDE scores between distinct risk groups (left) and their liner dependence (right). D Sensitivity prediction of chemotherapeutic regents in different groups. (***p < 0.001)